drugset / Trial / NCT00492076
Efficacy and Safety Trial of Subcutaneous Immunotherapy in Mite Induced Asthma
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to determine whether a short course of subcutaneous immunotherapy is efficacious in mite induced asthma. The efficacy is based on reduction in control medication.
Timeline
- Start
- 2006-10
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pangramin Plus D. pteronyssinus | Other / unclassified | — | Subcutaneous |